PMEF
ALT icon

Point72 Middle East FZE’s Altimmune ALT Stock Holding History

Point72 Middle East FZE’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,097
Closed -$42.7K – 1420
2023
Q2 		$42.7K Buy
12,097
+3,764
+45% +$16.9K ﹤0.01% 1313
2023
Q1 		$35.2K Buy
+8,333
New +$99K ﹤0.01% 1332

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Point72 Middle East FZE's ALT Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Altimmune (ALT) in Q3 2023, closing a stake of 12,097 shares — an estimated $42.7K sold.

Point72 Middle East FZE first reported a position in ALT in Q1 2023 and held it in 2 quarters. The position peaked at $42.7K in Q2 2023. 112 funds tracked by Wall St. Rank hold ALT as of Q3 2023.

  • Point72 Middle East FZE reported no remaining Altimmune position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 12,097 Altimmune shares in Q3 2023, an estimated $42.7K.
  • Point72 Middle East FZE first reported a position in Altimmune in Q1 2023 and held it in 2 quarters.
  • Point72 Middle East FZE's Altimmune position peaked at $42.7K in Q2 2023.
  • 112 funds tracked by Wall St. Rank held Altimmune as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.